Terah Krigsvold was appointed Director of INVO Fertility, Inc., effective December 30, 2025. As of November 14, 2026, INVO Fertility, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on January 6, 2026, naming 1 appointment (Form 8-K, January 6, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like INVO Fertility, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
INVO Fertility, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-01-06. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as INVO Fertility, Inc. files it.
Also on the record for INVO Fertility, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 9, 2026 | Stake report, Schedule 13G/A, by Glenbrook Capital Management | 1.4% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 4.99% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G, by Alumni Capital LP | 9.99% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 9.99% of the class | 5%+ stakes | Source |
| April 1, 2026 | Stake report, Schedule 13G, by GLENBROOK CAPITAL MANAGEMENT | 8.33% of the class | 5%+ stakes | Source |
| February 18, 2026 | Acquired Family Beginnings P.C | $400K | Acquisition | Source |
| February 17, 2026 | Stake report, Schedule 13G, by Armistice Capital, LLC | 9.99% of the class | 5%+ stakes | Source |
| January 21, 2026 | Stake report, Schedule 13G/A, by Five Narrow Lane LP | 0.29% of the class | 5%+ stakes | Source |
| October 28, 2025 | Stake report, Schedule 13G, by Greenblock Capital, LLC | 9.99% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs INVO Fertility, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on INVO Fertility, Inc. and the records around it.
INVO Fertility, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Acquisition Feb 2026
- Who owns it
Companies that share a holder
- Glenbrook Capital Management also filed stake reports on 1 other company: SenesTech, Inc. (Oct 2026)
- Five Narrow Lane LP also filed stake reports on 4 other companies: Expion Energy, Inc. (Aug 2026), BLACKBOXSTOCKS INC. (Apr 2026)
- Alumni Capital LP also filed stake reports on 12 other companies: reAlpha Tech Corp. (Nov 2026), Sports Entertainment Gaming Global Corp (Nov 2026), NEXALIN TECHNOLOGY, INC. (Aug 2026)
Watch INVO Fertility, Inc.
Get an email when INVO Fertility, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on INVO Fertility, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on INVO Fertility, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on INVO Fertility, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-01-06 | In | Director | 2025-12-30 | 8-K, 2026-01-06 |
Who leads INVO Fertility, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Terah Krigsvold, appointed, effective 2025-12-30 (filed 2026-01-06).
New leaders reset buying decisions — get the Full Report on INVO Fertility, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at INVO Fertility, Inc., with the record behind each one.
Find candidates like Director at INVO Fertility, Inc.Every change, in the filing's words
Appointed: Terah Krigsvold, Director, effective 2025-12-30
Effective December 30, 2025, the board of directors (the "Board") of INVO Fertility, Inc. (the "Company") appointed Terah Krigsvold as the Company's chief financial officer.
- Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
- Pursuant to that certain amended and restated employment agreement by and between the Company and Ms. Krigsvold (the "Krigsvold Amended and Restated Employment Agreement"), the Company has agreed to pay Ms. Krigsvold an annual salary of $250,000.
- Ms. Krigsvold is also eligible to earn bonus compensation of up to 50% of the base salary as determined by the Board and based on performance milestones.
- In addition to her base salary and performance bonus, Ms. Krigsvold is eligible to receive grants under the Company's 2019 Stock Incentive Plan (the "Plan").
- Terah Krigsvold, 43, has served as the Company's controller since December 3, 2020.
- Ms. Krigsvold has 9 years' experience in different finance and accounting roles.
- Ms. Krigsvold previously worked as a controller at Eastside Distilling (ticker: EAST), and a revenue accountant at Oregon Liquor Control Commission.
- Ms. Krigsvold earned a BS (2014) and MS (2016) in Accounting from Western Governors University.
- Appointment of Chief Business Officer Effective December 30, 2025, the Board accepted the resignation of Andrea Goren as the Company's chief financial officer and appointment him as chief business officer.
Tools for this story
Each opens in a new tab, filled in for INVO Fertility, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
